Evolent Health, Inc.EVHNYSE
LOADING
|||
Switch Symbol:
Revenue Growth Accelerating
Trending higher.
Left:
||||
Year-over-year revenue growth rate
Latest
7.92%
↑ 12% above average
Average (39q)
7.06%
Historical baseline
Range
High:46.17%
Low:-25.19%
CAGR
-1.4%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 7.92% |
| Q2 2025 | -8.13% |
| Q1 2025 | -25.19% |
| Q4 2024 | 4.05% |
| Q3 2024 | -3.98% |
| Q2 2024 | 1.17% |
| Q1 2024 | 15.03% |
| Q4 2023 | 8.81% |
| Q3 2023 | 8.93% |
| Q2 2023 | 9.69% |
| Q1 2023 | 11.83% |
| Q4 2022 | 8.47% |
| Q3 2022 | 10.20% |
| Q2 2022 | 7.70% |
| Q1 2022 | 19.61% |
| Q4 2021 | 11.64% |
| Q3 2021 | 0.19% |
| Q2 2021 | 3.25% |
| Q1 2021 | -20.91% |
| Q4 2020 | 13.50% |
| Q3 2020 | 10.25% |
| Q2 2020 | -1.78% |
| Q1 2020 | -6.47% |
| Q4 2019 | 7.44% |
| Q3 2019 | 14.68% |
| Q2 2019 | -2.93% |
| Q1 2019 | 2.41% |
| Q4 2018 | 28.78% |
| Q3 2018 | 3.91% |
| Q2 2018 | 3.28% |
| Q1 2018 | 22.85% |
| Q4 2017 | 5.39% |
| Q3 2017 | 0.79% |
| Q2 2017 | 0.78% |
| Q1 2017 | 20.71% |
| Q4 2016 | 46.17% |
| Q3 2016 | 6.53% |
| Q2 2016 | 14.30% |
| Q1 2016 | 7.36% |
| Q4 2015 | 13.99% |